Please assess the completion status of the following clinical trial:

Trial Title: Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women in the Philippines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female, 18 to 45 years old,~* SF levels \<25 µg/L,~* Hb levels 11-15.5 g/dL~* Normal Body Mass Index (18.5-25 kg/m2),~* In possession of a mobile phone on which the study app can be loaded~* Signed informed consent~Exclusion Criteria:~* Elevated CRP \> 5 mg/L~* Any metabolic, gastrointestinal, kidney or chronic disease such as diabetes, renal failure, hepatic dysfunction, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement) affecting iron metabolism,~* Use of medication which may interfere with iron absorption, gut physiology and iron metabolism~* Consumption of iron supplements within 2 weeks prior to study start and of additional iron supplements during the study period~* Difficulties with blood sampling,~* Known hypersensitivity or allergy to iron or placebo capsules in the given amount (ferrous sulfate, mannitol, silica)~* Pregnancy, breastfeeding~* Known or suspected non-compliance, drug or alcohol abuse~* Cigarette smokers

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Consecutive Day Dosing (Type: ACTIVE_COMPARATOR): This arm will daily receive iron capsules for 3 months, followed by daily placebo capsules for 3 months.
- Alternate Day Dosing (Type: EXPERIMENTAL): This arm will receive iron capsules alternating with placebo capsules for 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).